Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF804B | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | IL24 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | TSPAN1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | ADD3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | CUTA | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | SEC24C | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | FOXD3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | EXTL1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | SLC25A13 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | OR52I1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |